摘要
为探讨解毒化浊促愈汤联合美沙拉嗪治疗溃疡性结肠炎的临床疗效,将160例溃疡性结肠炎患者,随机分为观察组与对照组,各80例。对照组采用美沙拉嗪口服及纳肛治疗,观察组在对照组基础上联合解毒化浊促愈汤保留灌肠治疗。比较2组结肠镜检查积分、症状积分及复发率。结果显示,观察组在结肠镜检查积分、黏液脓血便积分、腹泻积分、腹痛积分及复发率上均低于对照组(P<0.05)。结果表明,解毒化浊促愈汤联合美沙拉嗪可有效改善溃疡性结肠炎患者预后,具有较高的临床应用价值。
This study was investigate the clinical effect of Jieduhuazhuocuyu Tang(a TCM formula,shortly named as Tang)combined with mesalazine in the treatment of ulcerative colitis(UC),randomly divided 160 UC patients into control group(80 cases,orally administered mesalazine,and by rectum)and observation group(80 cases,added Tang for retention enema,based on control group);then,compared both groups’ score on colonoscopy,and on symptoms,as well as recurrence rate.As results,in the score on colonoscopy,and in the score on mucous pus &blood stool,on diarrhea,and on abdominal pain,as well as in recurrence rate observation group was all lower than control group(P <0.05).Results show that Tang plus mesalazine can effiectively improve patients’ prognosis.It has higher clinical application value.
作者
王凯
韩晓丽
马炳旭
刘利萍
WANG Kai;HAN Xiao-li;MA Bing-xu;LIU Li-ping(Henan Provincial Hospital of TCM,Zhengzhou,Henan 450002;Henan University of TCM,Zhengzhou,Henan 450002)
出处
《中国肛肠病杂志》
2019年第9期27-28,共2页
Chinese Journal of Coloproctology
